Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2025 16:03 ET | Source: Vine Hill Capital Investment Corp. II

Vine Hill Capital Investment Corp. II Announces Closing of Upsized $230 Million Initial Public Offering

Fort Lauderdale, Florida, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vine Hill Capital Investment Corp. II (the “Company”), a special purpose acquisition company, today announced the closing of its upsized...
December 19, 2025 16:01 ET | Source: Aclaris Therapeutics, Inc.

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index
December 19, 2025 16:01 ET | Source: The Rosen Law Firm PA

KLAR Announcement: If You Have Suffered Losses in Klarna Group plc (NYSE: KLAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Klarna...
December 19, 2025 16:00 ET | Source: TrustCo Bank Corp NY

TrustCo Bank Corp NY Announces Two-Million Share Stock Repurchase Program

GLENVILLE, N.Y., Dec. 19, 2025 (GLOBE NEWSWIRE) -- TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) (the “Company” or “TrustCo”) today announced that its Board of Directors has approved a new stock...
December 19, 2025 16:00 ET | Source: Cytokinetics, Incorporated

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company’s First...
December 19, 2025 16:00 ET | Source: Zealand Pharma

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 26 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
December 19, 2025 15:59 ET | Source: The Rosen Law Firm PA

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRGO

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023...
December 19, 2025 15:57 ET | Source: The Rosen Law Firm PA

ROSEN, LEADING INVESTOR COUNSEL, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JYD

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jayud Global Logistics Ltd. (NASDAQ: JYD) between April 21,...
December 19, 2025 15:34 ET | Source: The Rosen Law Firm PA

ROSEN, A TOP RANKED LAW FIRM, Encourages Bitdeer Technologies Group Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTDR

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6,...
December 19, 2025 15:33 ET | Source: The Rosen Law Firm PA

ROSEN, A TOP RANKED LAW FIRM, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OWL

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025...

1 ...20 21 22 ...315155